Credit: CC0 Public Domain The marketing of direct-to-consumer “neurotechnologies” can be enticing: apps that diagnose a mental state, and brain devices that improve cognition or “read” one’s emotional state. However, many of these increasingly popular products aren’t fully supported by science and have little to no regulatory oversight, which poses potential health risks to the […]Continue Reading ...
The marketing of direct-to-consumer “neurotechnologies” can be enticing: apps that diagnose a mental state, and brain devices that improve cognition or “read” one’s emotional state. However, many of these increasingly popular products aren’t fully supported by science and have little to no regulatory oversight, which poses potential health risks to the public. In a new […]Continue Reading ...
April 25, 2018 Direct-to-consumer telemedicine is a viable way to deliver medical care in the days following a natural disaster, although most people who use such services do so for routine matters rather than disaster-caused illnesses, according to a new RAND Corporation study. Examining the experience of one direct-to-consumer service in the weeks following Hurricanes […]Continue Reading ...
May 15, 2018 According to a position statement from the American Academy of Sleep Medicine (AASM), consumer sleep technology must be cleared by the Food and Drug Administration (FDA) and rigorously tested if it is intended to diagnose or treat sleep disorders. Consumer sleep technologies are non-prescription devices such as wearables and mobile apps that […]Continue Reading ...
July 28, 2017 A learn about printed on-line in a nature magazine Medical Studies means that speaking within the 1/3 consumer to oneself in annoying instances would possibly assist controlling feelings and it wishes no further psychological effort than first consumer self-talk, which is typically utilized by folks to speak to themselves. The learn about […]Continue Reading ...
- Biologist uses new grant to find ways to eliminate schistosomiasis
- Bag-mask ventilation to help patients breathe during intubation prevents complications
- AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
- Nature versus nurture and addiction
- New website connects researchers with data experts, resources | News Center
- Today’s Concerns About Drug Prices Echo The Past
- CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
- Study finds out similarity in function between healthy retina cell and tumor cell
- CWRU awarded NIH grant to identify effective treatments for intimate partner violence
- Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
- Scientists discover new type of immune cells that are essential for forming heart valves
- Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
- Genetic defect linked to pediatric liver disease identified
- New cellular atlas could provide a deeper insight into blinding diseases
- Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
- Innovative compound offers a new therapeutic approach to treat multiple sclerosis
- $1.5 million grant to develop opioid treatment program for jail detainees
- FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
- Most Hip, Knee Replacements Last Decades, Study Finds
- Wellness problems prevalent among ob-gyn residents